Phase 3 Study of BK1310 in Healthy Infants

NCT02992925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunization; Infection

Interventions

BIOLOGICAL: DPT-IPV-Hib-High（Combined Vaccine）
BIOLOGICAL: DPT-IPV-Hib-Low（Combined Vaccine）
BIOLOGICAL: Hib vaccine
BIOLOGICAL: DPT-IPV

Sponsor

Tanabe Pharma Corporation

Collaborators

[object Object]